![Antonio F. Cruz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antonio F. Cruz
Directeur Général chez
TRANSITION THERAPEUTICS INC
Profil
Antonio F.
Cruz was the founder of Angiotech Pharmaceuticals, Inc. (founded in 1992) where he held the title of Director & Vice President.
He is also the founder of Transition Therapeutics, Inc. (founded in 1998) where he serves as the Chief Executive Officer.
Dr. Cruz currently holds the position of Chairman & Chief Executive Officer at NeuroMedix, Inc. He is also a Director at Treat U SA, Accel-Rx, and Mercal Capital Corp.
(since 2015).
Dr. Cruz has previously served as the President & Chief Executive Officer of the Canadian Arthritis Network.
He has also been a Director at Ellipsis Neurotherapeutics, Inc., BIOTECanada, and Mount Sinai Hospital (Canada) where he held the title of Senior Scientist.
Postes actifs de Antonio F. Cruz
| Sociétés | Poste | Début |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Directeur Général | 06/07/1998 |
NeuroMedix, Inc.
 NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Général | - |
Treat U SA
 Treat U SA BiotechnologyHealth Technology Develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area | Directeur/Membre du Conseil | - |
Mercal Capital Corp.
 Mercal Capital Corp. MiscellaneousMiscellaneous Functions as an investment holding company | Directeur/Membre du Conseil | 31/08/2015 |
Accel-Rx
 Accel-Rx Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | - |
Anciens postes connus de Antonio F. Cruz
| Sociétés | Poste | Fin |
|---|---|---|
Canadian Arthritis Network
 Canadian Arthritis Network Miscellaneous Commercial ServicesCommercial Services Operates as a arthritis research community | President | 01/01/2001 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | - |
Mount Sinai Hospital (Canada)
 Mount Sinai Hospital (Canada) Hospital/Nursing ManagementHealth Services Operates hospital | Directeur Technique/Scientifique/R&D | - |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Fondateur | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Ellipsis Neurotherapeutics, Inc.
 Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Mount Sinai Hospital (Canada)
Mount Sinai Hospital (Canada) Hospital/Nursing ManagementHealth Services Operates hospital | Health Services |
Canadian Arthritis Network
Canadian Arthritis Network Miscellaneous Commercial ServicesCommercial Services Operates as a arthritis research community | Commercial Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Treat U SA
Treat U SA BiotechnologyHealth Technology Develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area | Health Technology |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Provides investment services | Finance |
Mercal Capital Corp.
Mercal Capital Corp. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
